Papers: 10.1186/1741-7015-10-20

https://doi.org/10.1186/1741-7015-10-20

Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?

Cited by: 56
Author(s): Iakov N. Rudenko, Ruth Chia, Mark Cookson
Published: over 13 years ago

Software Mentions 1